动机访谈联合认知行为疗法治疗精神分裂症动机性阴性症状
MI-CBT组在急性治疗期动机性阴性症状改善显著优于对照组,随访期相对基线获益维持,但组间差异减弱。社区功能与瞳孔测量生物标志物变化不显著。
要点
- MI-CBT在急性治疗期显著改善动机性阴性症状,随访期获益维持。
- 社区功能与瞳孔测量认知努力标志物的组间差异不显著。
- 阴性症状通常被认为难以干预,本研究提示联合心理社会干预可行。
核心结论
- 动机访谈联合CBT可改善精神分裂症动机性阴性症状,且获益在随访期维持。
研究设计与样本
- 研究含12周积极治疗与12周随访,共三个时间点评估。
主要发现
- MI-CBT组动机性阴性症状在急性治疗期改善显著优于对照组。
- MI-CBT组相对基线获益在随访期维持,但相对对照组的差异减弱。
- 社区功能改善与瞳孔测量认知努力标志物的组间变化均不显著。
临床怎么用
- 对伴中重度动机性阴性症状的精神分裂症患者,可考虑MI-CBT联合干预。
- 干预获益主要在阴性症状维度,向日常功能泛化仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Negative symptoms are a primary cause of disability in schizophrenia for which there are no established pharmacotherapies. This study evaluated a novel psychosocial intervention that combined two evidence-based practices-motivational interviewing and cognitive-behavioral therapy (MI-CBT)-for the treatment of motivational negative symptoms. METHODS: Seventy-nine participants with schizophrenia and moderate to severe negative symptoms were included in a randomized controlled trial comparing the 12-session MI-CBT treatment with a mindfulness control condition. Participants were assessed at three time points through the study period, which included 12 weeks of active treatment and 12 weeks of follow-up. The primary outcome measures were motivational negative symptoms and community functioning; the secondary outcomes included a posited biomarker of negative symptoms: pupillometric response to cognitive effort. RESULTS: Compared with the control group, participants in the MI-CBT group showed significantly greater improvements in motivational negative symptoms over the acute treatment period. Their gains relative to baseline were maintained at follow-up, although the differential benefit relative to control subjects was attenuated. There were nonsignificant effects toward improvements in community functioning and differential change in the pupillometric markers of cognitive effort. CONCLUSIONS: The results show that combining motivational interviewing with CBT yields improvements in negative symptoms, a feature of schizophrenia generally thought of as resistant to intervention. Motivational negative symptoms not only responded to the novel treatment, but the gains were maintained over the follow-up period. Implications for future studies and for improving the generalization of the negative symptom gains to daily functioning domains are discussed.
引用
- Reddy LF, Glynn SM, McGovern JE, et al. A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT. Am J Psychiatry. 2023. PMID: 36891649. doi:10.1176/appi.ajp.20220243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。